Acarix AB (OSTO:ACARIX) Additional Paid-In Capital : kr638.20 Mil(As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Acarix AB Additional Paid-In Capital?

Acarix AB's quarterly additional paid-in capital increased from Sep. 2023 (kr549.01 Mil) to Dec. 2023 (kr592.15 Mil) and increased from Dec. 2023 (kr592.15 Mil) to Mar. 2024 (kr638.20 Mil).

Acarix AB's annual additional paid-in capital increased from Dec. 2021 (kr494.96 Mil) to Dec. 2022 (kr519.56 Mil) and increased from Dec. 2022 (kr519.56 Mil) to Dec. 2023 (kr592.15 Mil).

Acarix AB Additional Paid-In Capital Historical Data

The historical data trend for Acarix AB's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acarix AB Additional Paid-In Capital Chart

Acarix AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

378.90

426.16

494.96

519.56

592.15

Acarix AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															519.56	549.21	549.01	592.15	638.20

Acarix AB Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Acarix AB Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Acarix AB's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Acarix AB (OSTO:ACARIX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Acarix AB (OSTO:ACARIX) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

ACIXF:USA 7AC:Germany

Address

World Trade Center Malmo, Jungmansgatan 12, Malmo, SWE, 211 19

Website

https://www.acarix.com

Acarix AB is a Swedish medical technology company that develops innovative solutions for rapid AI-based exclusion of coronary artery disease (CAD). The CE-marked CADScor System, which has also received DeNovo approval from the FDA, is intended for patients experiencing chest pain with suspected coronary artery disease and is designed to help reduce millions of cases of unnecessary, invasive, and costly diagnostics. The CADScor System uses advanced acoustics and AI technology to non-invasively rule out CAD in less than 10 minutes, with at least 96% certainty.

Acarix AB (OSTO:ACARIX) Headlines

No Headlines